about
Clinical studies in lysosomal storage diseases: Past, present, and futurePharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises.Substrate reduction therapy for Krabbe's disease.GGDonto ontology as a knowledge-base for genetic diseases and disorders of glycan metabolism and their causative genes.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Therapeutic approaches for lysosomal storage diseases
@ast
Therapeutic approaches for lysosomal storage diseases
@en
Therapeutic approaches for lysosomal storage diseases
@nl
type
label
Therapeutic approaches for lysosomal storage diseases
@ast
Therapeutic approaches for lysosomal storage diseases
@en
Therapeutic approaches for lysosomal storage diseases
@nl
prefLabel
Therapeutic approaches for lysosomal storage diseases
@ast
Therapeutic approaches for lysosomal storage diseases
@en
Therapeutic approaches for lysosomal storage diseases
@nl
P2860
P356
P1476
Therapeutic approaches for lysosomal storage diseases
@en
P2093
Gregory M Pastores
P2860
P304
P356
10.1177/2042018810384429
P577
2010-08-01T00:00:00Z